© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Mission: Our mission is to build a global, patient-forward, cancer learning network where peer and professional navigators guide patients through the innovations of today’s molecular medicine.
View our program brochure here
Connect with us:
First Patient Receives Treatment With Investigational CAR-T Cell Therapy-Opdivo Combo for Hodgkin Lymphoma
New Study to Explore Safety and Efficacy of a Single-Infusion CAR-T Cell Treatment in Patients With Colon Cancer
I Don’t Regret My Choice to Forgo Chemotherapy
FDA OKs New Drug Application for Momelotinib to Treat Myelofibrosis